163 related articles for article (PubMed ID: 12240362)
1. Dodeca(carboranyl)-substituted closomers: toward unimolecular nanoparticles as delivery vehicles for BNCT.
Thomas J; Hawthorne MF
Chem Commun (Camb); 2001 Sep; (18):1884-5. PubMed ID: 12240362
[TBL] [Abstract][Full Text] [Related]
2. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
3. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
4. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
[TBL] [Abstract][Full Text] [Related]
5. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble carboranyl-phthalocyanines for BNCT. Synthesis, characterization, and in vitro tests of the Zn(II)-nido-carboranyl-hexylthiophthalocyanine.
Pietrangeli D; Rosa A; Pepe A; Altieri S; Bortolussi S; Postuma I; Protti N; Ferrari C; Cansolino L; Clerici AM; Viola E; Donzello MP; Ricciardi G
Dalton Trans; 2015 Jun; 44(24):11021-8. PubMed ID: 25995094
[TBL] [Abstract][Full Text] [Related]
9. Water-Soluble
Nakagawa F; Kawashima H; Morita T; Nakamura H
Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
[TBL] [Abstract][Full Text] [Related]
10. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.
Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; Viñas C; Suzuki M; Ono K; Nakamura H
Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD-Functionalized
Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells.
Crossley EL; Issa F; Scarf AM; Kassiou M; Rendina LM
Chem Commun (Camb); 2011 Nov; 47(44):12179-81. PubMed ID: 21993200
[TBL] [Abstract][Full Text] [Related]
14. Sterically hindered and robust pnictogen ligands derived from carboranes: synthesis and X-ray structure determination of tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine, tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))arsine and chloro(tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine)gold(I).
King AS; Ferguson G; Britten JF; Valliant JF
Inorg Chem; 2004 May; 43(11):3507-13. PubMed ID: 15154815
[TBL] [Abstract][Full Text] [Related]
15. Enlargement of a Modular System-Synthesis and Characterization of an
Kellert M; Lönnecke P; Riedl B; Koebberling J; Hey-Hawkins E
Molecules; 2019 Sep; 24(18):. PubMed ID: 31509949
[TBL] [Abstract][Full Text] [Related]
16. Alpha (α-) and beta (β-carboranyl-C-deoxyribosides: syntheses, structures and biological evaluation.
Šnajdr I; Janoušek Z; Takagaki M; Císařová I; Hosmane NS; Kotora M
Eur J Med Chem; 2014 Aug; 83():389-97. PubMed ID: 24980120
[TBL] [Abstract][Full Text] [Related]
17. Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).
Nakase I; Katayama M; Hattori Y; Ishimura M; Inaura S; Fujiwara D; Takatani-Nakase T; Fujii I; Futaki S; Kirihata M
Chem Commun (Camb); 2019 Nov; 55(93):13955-13958. PubMed ID: 31617510
[TBL] [Abstract][Full Text] [Related]
18. Primary Amine Nucleophilic Addition to Nitrilium
Nelyubin AV; Selivanov NA; Bykov AY; Klyukin IN; Novikov AS; Zhdanov AP; Karpechenko NY; Grigoriev MS; Zhizhin KY; Kuznetsov NT
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948186
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
20. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
